Walgreens Boots Alliance, Inc. (WBA)
NASDAQ: WBA · Real-Time Price · USD
11.64
0.00 (0.00%)
At close: Aug 1, 2025, 4:00 PM
11.68
+0.04 (0.34%)
After-hours: Aug 1, 2025, 7:39 PM EDT
HashiCorp Market Cap
Walgreens Boots Alliance has a market cap or net worth of $10.08 billion as of August 1, 2025. Its market cap has decreased by -1.51% in one year.
Market Cap
10.08B
Enterprise Value
39.24B
1-Year Change
-1.51%
Ranking
Category
Stock Price
$11.64
Market Cap Chart
Since December 1, 1998, Walgreens Boots Alliance's market cap has decreased from $26.43B to $10.08B, a decrease of -61.88%. That is a compound annual growth rate of -3.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 10.08B | 24.89% |
Dec 31, 2024 | 8.07B | -64.24% |
Dec 29, 2023 | 22.56B | -30.19% |
Dec 30, 2022 | 32.31B | -28.44% |
Dec 31, 2021 | 45.15B | 30.75% |
Dec 31, 2020 | 34.53B | -34.38% |
Dec 31, 2019 | 52.62B | -18.37% |
Dec 31, 2018 | 64.47B | -12.07% |
Dec 29, 2017 | 73.31B | -18.22% |
Dec 30, 2016 | 89.65B | -3.30% |
Dec 31, 2015 | 92.72B | 28.67% |
Dec 31, 2014 | 72.06B | 32.03% |
Dec 31, 2013 | 54.58B | 56.03% |
Dec 31, 2012 | 34.98B | 21.12% |
Dec 30, 2011 | 28.88B | -20.28% |
Dec 31, 2010 | 36.22B | -0.24% |
Dec 31, 2009 | 36.31B | 48.76% |
Dec 31, 2008 | 24.41B | -35.35% |
Dec 31, 2007 | 37.75B | -18.02% |
Dec 29, 2006 | 46.05B | 2.80% |
Dec 30, 2005 | 44.79B | 14.25% |
Dec 31, 2004 | 39.21B | 5.12% |
Dec 31, 2003 | 37.30B | 24.67% |
Dec 31, 2002 | 29.92B | -12.87% |
Dec 31, 2001 | 34.34B | -18.93% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 664.39B |
Johnson & Johnson | 396.75B |
AbbVie | 333.89B |
AstraZeneca | 232.21B |
UnitedHealth Group | 226.39B |
Novartis AG | 224.47B |
Abbott Laboratories | 219.63B |
Novo Nordisk | 213.92B |